Introduction to AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom, with major operational hubs in Gaithersburg, Maryland, USA, and Södertälje, Sweden. With over 83,000 employees and annual revenues exceeding $45 billion, AstraZeneca is recognized as a top-tier innovator in the healthcare industry, particularly in the fields of oncology, cardiovascular, renal, metabolic, respiratory, and autoimmune diseases. The company's reputation as a leader is built on a robust pipeline of novel therapies and a commitment to translating scientific discoveries into life-changing medicines. Healthcare organizations, research institutions, and governments rely on AstraZeneca's cutting-edge treatments and collaborative research models to address some of the world's most pressing health challenges. The AstraZeneca company profile is synonymous with integrity, patient-centricity, and a relentless pursuit of scientific excellence, making it a preferred partner for clinical trials and drug development programs globally.

Company History and Business Evolution

AstraZeneca was formed in 1999 through the merger of the Swedish company Astra AB and the British company Zeneca Group plc. Astra AB, founded in 1913, had a strong heritage in respiratory and gastrointestinal therapies, while Zeneca, demerged from Imperial Chemical Industries (ICI) in 1993, brought expertise in oncology and cardiovascular medicine. The merger created a powerful R&D engine that quickly advanced into blockbuster drugs such as Nexium (esomeprazole) and Crestor (rosuvastatin). Over the next two decades, AstraZeneca expanded through strategic acquisitions, including MedImmune in 2007 (boosting biologics and vaccines), and later Acerta Pharma in 2015 (strengthening oncology pipeline with Calquence). The company's evolution has been marked by bold moves into immuno-oncology, precision medicine, and digital health. In 2020, AstraZeneca partnered with the University of Oxford to develop and distribute the COVID-19 vaccine (Vaxzevria), demonstrating global agility and manufacturing scale. Today, AstraZeneca is a top 10 pharmaceutical company by revenue, with a pipeline of over 150 projects and a strong focus on sustainability and equitable access to medicines. The company's history is one of continuous reinvention, moving from small-molecule dominance to a diversified portfolio of biologics, gene therapies, and cell therapies.

AstraZeneca at a Glance

• Headquarters: Cambridge, UK (Global HQ) and Gaithersburg, MD, USA (US HQ)
• Founded: 1999 (merger of Astra AB and Zeneca Group)
• CEO: Pascal Soriot
• Revenue (2023): $45.81 billion
• Employees: ~83,000
• Industry: Biopharmaceuticals / Healthcare
• Key Therapeutic Areas: Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, Vaccines
• Major Products: Tagrisso, Lynparza, Imfinzi, Farxiga, Symbicort, Calquence, Ultomiris
• R&D Spend (2023): ~$10.6 billion
• Stock Symbol: AZN (NYSE / LSE)
• Global Reach: Operations in over 100 countries
• Manufacturing Sites: 20+ across the globe
• Clinical Trials: ~300 active studies annually
• Patent Expirations: Nexium (2008), Crestor (2016)
• Pipeline Priority: Oncology (60% of projects)
• Sustainability Goals: Carbon negative by 2030
• Awards: Forbes World's Best Employers, Science Top 100 Employers
• Digital Health: Partnerships with AI and data analytics firms
• Regulatory Status: FDA, EMA, MHRA approvals
• Corporate Citizenship: Access to Medicines, health equity funds

Mission, Vision, and Core Corporate Values

Mission: Push the boundaries of science to deliver life-changing medicines to patients worldwide. Vision: To be the world’s most innovative and trusted biopharmaceutical company. AstraZeneca’s core values are embedded in the acronym F.A.I.R. – Follow the science, Act with integrity, Include everyone, and Respect the environment. These values guide decision-making from early-stage research to commercialization. The company places a strong emphasis on patient centricity, ensuring that all activities are ultimately aimed at improving health outcomes. This mission-driven culture attracts top talent who are passionate about making a tangible difference in global health.

Business Strategy and Future Roadmap

AstraZeneca’s strategy is built on three pillars: Innovation, Growth, and Trust. In oncology, the company aims to deliver combination therapies and personalized medicine using biomarkers and companion diagnostics. In non-oncology areas, AstraZeneca is focusing on chronic disease management and novel mechanisms, such as Brilinta for cardiovascular disease and Farxiga expanding into heart failure and chronic kidney disease. The future roadmap includes expansion into cell and gene therapies, RNA therapeutics, and digital health platforms that improve patient adherence and real-world evidence generation. AstraZeneca also targets emerging markets, especially China, which represents a significant growth driver. The company plans to launch at least 15 new molecular entities by 2030. Additionally, sustainability and health equity are integrated into business operations, with goals to achieve carbon negativity and provide access to medicines for 100 million people in low- and middle-income countries by 2030.

Products, Technologies, and Services

Products: AstraZeneca’s portfolio includes over 20 marketed drugs covering oncology (Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu), cardiovascular (Brilinta, Farxiga), respiratory (Symbicort, Breztri), and rare diseases (Soliris, Ultomiris). The company also has a vaccines division, leveraging the COVID-19 vaccine technology for a pipeline of respiratory syncytial virus (RSV) and other infectious disease vaccines. Technologies: AstraZeneca invests heavily in platform technologies such as antibody-drug conjugates (ADCs), bispecific antibodies, gene editing, and artificial intelligence for drug discovery. The company operates state-of-the-art R&D centers in the UK, US, Sweden, and China. Services: While primarily a developer and manufacturer, AstraZeneca offers clinical trial services through its Patient-Centric Clinical Development model, partnering with CROs and academic institutions. The company also provides patient support programs and disease education initiatives.

Industries and Markets Served

AstraZeneca serves the pharmaceutical, biotechnology, and healthcare delivery industries, with products used in hospitals, specialty clinics, and retail pharmacies. Its markets are divided into developed regions (US, Europe, Japan) and emerging markets (China, India, Latin America, Africa). The oncology market is the largest revenue contributor, followed by cardiovascular and respiratory. AstraZeneca also participates in the vaccines and rare disease markets. Key customer segments include oncologists, cardiologists, pulmonologists, nephrologists, and primary care physicians, as well as health systems, insurance companies, and government agencies.

Leadership and Management Philosophy

CEO Pascal Soriot has led AstraZeneca since 2012, transforming it from a company facing patent cliffs into a high-growth innovation powerhouse. He advocates a patient-first, science-driven culture with an emphasis on agility and ownership. The executive committee includes leaders with deep scientific backgrounds, such as Mene Pangalos (R&D), Iskra Reic (International), and Dave Fredrickson (Oncology). AstraZeneca promotes a matrixed structure that empowers cross-functional teams. Management philosophy centers on accountability, innovation, and inclusion, with regular town halls and open dialogue. The company invests in leadership development programs and encourages internal mobility.

Corporate Events, Conferences, and Community Engagement

AstraZeneca is a prominent sponsor of major medical congresses, including ASCO, ESMO, AHA, ERS, and ADA, where it presents landmark clinical data. The company hosts its own annual Science Day and Innovation Awards. Community engagement includes global health programs like Young Health Programme (addressing non-communicable disease risks in youth) and Access to Heart (improving cardiovascular care in underserved areas). AstraZeneca also participates in the UN Global Compact and has a strong volunteerism culture. In 2023, employees contributed over 1 million volunteer hours.

Employees and Workplace Culture

AstraZeneca is consistently recognized as a top employer, with a culture centered on innovation, diversity, and well-being. The company offers flexible working, comprehensive benefits, and learning platforms such as AstraZeneca University. Employee networks include Women’s Network, LGBTQ+ Pride, and Multicultural Council. The company has a strong commitment to mental health and provides employee assistance programs. Awards include Forbes Best Employers for Women and Science Top Employer. The workplace environment is described as high-energy, collaborative, and purpose-driven.

Job Details & Requirements for this Posting

Position: Senior Medical Science Liaison – Oncology (Immuno-Oncology)

Location: Remote (Field-based, must reside in assigned territory within US)

Salary Range: $150,000 – $200,000 base + bonus, stock, and car allowance

Job Type: Full-time, Remote

Department: Medical Affairs, US Oncology

Responsibilities:

• Develop and maintain scientific relationships with Key Opinion Leaders (KOLs), investigators, and healthcare professionals in immuno-oncology.
• Provide medical and scientific expertise across product lifecycles, including pre- and post-launch phases.
• Deliver high-quality scientific presentations at advisory boards, investigator meetings, and external congresses.
• Facilitate clinical trial site identification and support investigator-initiated studies (IIS).
• Gather and communicate competitive intelligence and medical insights to internal stakeholders.
• Ensure compliance with all regulatory and company policies regarding off-label information and scientific exchange.

Qualifications:

• Advanced degree required: PharmD, MD, PhD in life sciences (preferably oncology-focused).
• Minimum 3-5 years of Medical Science Liaison experience in the pharmaceutical/biotech industry.
• Deep knowledge of immuno-oncology and immunotherapy mechanisms.
• Excellent communication and presentation skills; ability to translate complex science to diverse audiences.
• Proven ability to work independently in a field-based, remote environment.
• Valid driver’s license and willingness to travel up to 60% within territory.

Why Join AstraZeneca?

• Be at the forefront of oncology innovation with one of the deepest pipelines in the industry.
• Collaborate with world-class scientists and KOLs shaping the future of cancer care.
• Attractive total rewards package: competitive salary, annual bonus, long-term incentives, generous 401k match, and comprehensive health benefits.
• Career growth opportunities across functions and geographies.
• Strong commitment to diversity, equity, and inclusion; employee resource groups and mentorship programs.

Customer Reviews and Industry Reputation

Glassdoor

On Glassdoor, AstraZeneca holds a 4.1 out of 5 rating based on over 10,000 reviews. Employees praise the company’s strong pipeline, collaborative culture, and excellent benefits. Common positives include “science-driven environment”, “great work-life balance”, and “supportive management”. Negatives often mention “complex matrix structures” and “bureaucracy”. The CEO approval rating is 84%, reflecting confidence in leadership. Reviews from medical affairs roles specifically highlight the autonomy and impact of the MSL function.

Indeed

Indeed reviews average 4.0 out of 5. Employees frequently note the “global reach” and “meaningful work” as top reasons to stay. Many reviews from sales and medical teams mention “competitive compensation” and “strong training programs”. Criticisms include “high pressure for results” and “slow decision-making”. Overall, Indeed reviewers recommend AstraZeneca to peers, especially those passionate about healthcare innovation.

Gartner Peer Insights

While more common for IT products, Gartner Peer Insights for pharmaceutical companies are limited. However, AstraZeneca’s digital health initiatives and partnerships have received favorable mentions from technology leaders. The company’s use of AI in drug discovery and patient engagement is noted as innovative.

Trustpilot

Trustpilot reviews for AstraZeneca as an employer are scarce, but the company’s patient-focused initiatives receive positive feedback. Some patient reviews acknowledge the impact of life-saving drugs like Tagrisso and Farxiga. Negative reviews occasionally address drug pricing, though this is industry-wide.

G2

G2 does not typically rate pharmaceutical companies directly, but AstraZeneca’s platforms and digital tools used by healthcare providers are reviewed. The company’s clinical trial portals and data analytics tools score well for usability and reliability.

Google Reviews

Google Reviews for AstraZeneca’s corporate offices average 4.3 stars. Employees and visitors highlight modern facilities, cafeteria quality, and security. The Cambridge campus particularly receives praise for its sustainable design and collaborative spaces. Overall sentiment is positive, with most reviewers recommending the company as an employer.

LinkedIn Reputation

On LinkedIn, AstraZeneca has over 2.5 million followers and is frequently listed as a top company by the platform. The company’s career page showcases employee testimonials and diversity initiatives. Industry professionals recognize AstraZeneca as a top innovator, and the brand’s reputation for integrity and science is strong. LinkedIn endorsements for senior leaders are high, and the company’s content marketing (like “Science Talks”) engages a broad audience.

Why Organizations Choose AstraZeneca

Healthcare organizations, contract research organizations, and academic institutions partner with AstraZeneca due to its scientific credibility, global scale, and patient access programs. The company’s willingness to share data, collaborate on trials, and support investigator-initiated studies makes it a preferred partner. AstraZeneca’s strong regulatory track record and quality manufacturing ensure reliable supply. For payers and providers, the value proposition includes evidence-based therapies that reduce long-term healthcare costs. Additionally, the company’s commitment to sustainability and ethical practices aligns with the values of modern healthcare systems.

Official Contact Information

For inquiries and assistance, please reach out to AstraZeneca using the following contact details:

Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
Contact Number: +44 (0)20 3749 5000
Support Number: +1 800-236-9933 (US Medical Information)
Helpdesk Number: +44 (0)20 3749 5000 (Main switchboard)
Website: www.astrazeneca.com

Official Social Media Presence

• LinkedIn:linkedin.com/company/astrazeneca
• Twitter (X):@AstraZeneca
• Facebook:facebook.com/AstraZeneca
• YouTube:youtube.com/user/AstraZeneca
• Instagram:@astrazeneca

SEO FAQ Section

AstraZeneca is known for its innovative medicines in oncology, cardiovascular, respiratory, and rare diseases, as well as its COVID-19 vaccine developed with Oxford University.

AstraZeneca is headquartered in Cambridge, United Kingdom, with a US corporate hub in Gaithersburg, Maryland.

The CEO of AstraZeneca is Pascal Soriot, who has led the company since 2012.

Top-selling drugs include Tagrisso, Imfinzi, Lynparza, Farxiga, Symbicort, and Calquence.

AstraZeneca employs approximately 83,000 people globally.

AstraZeneca reported revenue of $45.81 billion in 2023.

Yes, oncology is AstraZeneca’s largest therapeutic area, representing over 60% of its pipeline.

Interested candidates can apply through the careers page on AstraZeneca’s official website.

AstraZeneca’s mission is to push the boundaries of science to deliver life-changing medicines.

Yes, AstraZeneca developed a COVID-19 vaccine and has a pipeline of vaccines for RSV and other infectious diseases.

AstraZeneca promotes a culture of innovation, inclusion, and patient-centricity, with flexible working and strong support for diversity.

The salary range for this role is typically $150,000 to $200,000 base plus bonus and benefits.

Benefits include competitive compensation, health insurance, retirement plans, stock options, paid time off, and learning opportunities.

Yes, AstraZeneca aims to be carbon negative by 2030 and has extensive health equity initiatives.

AstraZeneca has employee resource groups, inclusive hiring practices, and global D&I targets.

AstraZeneca is committed to sharing clinical trial data and results publicly to advance science.

Yes, AstraZeneca offers remote and field-based roles, particularly in medical affairs and sales.

AstraZeneca is highly regarded for its scientific innovation, strong pipeline, and ethical practices.

Yes, AstraZeneca has internships, co-op programs, and graduate development initiatives globally.

Investor relations can be reached through the company’s website or by calling +44 (0)20 3749 5000.

For a comprehensive overview of corporate and industry resources, visit AstraZeneca’s official site. Additionally, explore opportunities for gaining visibility and authority in the pharmaceutical field through strategic content placements, such as utilizing Paid Guest Posting Sites to amplify thought leadership. Guest Post Backlinks and SEO Guest Posting Services can further enhance online presence, complemented by Guest Post Outreach Services and Order Guest Posting Service packages. For those seeking scalable solutions, explore Guest Post Packages Pricing and Buy Guest Post Packages to drive targeted traffic.